Skip to main content
SpringerLink
Log in
Book cover

Gynäkologische Onkologie pp 315–331Cite as

Trophoblasttumoren

  • Chapter

  • 32 Accesses

Zusammenfassung

Die gestationsbedingten Trophoblasterkrankungen (GTE) umfassen eine heterogene Gruppe von Krankheitsbildern einschließlich Blasenmole, invasiver Mole und Chorionkarzinom. GTE sind durch eine abnormale Proliferation von Trophoblastgewebe charakterisiert und leiten sich vom fetalen Gewebe ab [Hammond 1988].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ayan A, Ergeneli M,Yüce K,Yapar E, Kisnisci A (1990) Effects of prophylactic chemotherapy for postmolar trophoblastic disease in patients with complete hydatidiform mole. Int J Gynecol Obstet 32: 39–41

    Google Scholar 

  • Azab M, Pejovic M, Theodore C, George M, Droz J, Bellet D, Michel G, Amiel J (1988) Prognostic factors in gestational trophoblastic tumors. Cancer 62: 585–592

    Article  PubMed  CAS  Google Scholar 

  • Azab M, Droz J, Theodore C, Wolff J, Amiel I (1988) Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 64: 1829–1832

    Article  Google Scholar 

  • Bagshawe K (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38: 1373

    Article  PubMed  CAS  Google Scholar 

  • Bagshawe K (1984) Treatment of high-risk choriocarcinoma. J Reprod Med 29:813–820

    PubMed  CAS  Google Scholar 

  • Bagshawe K, Dent J, Webb J (1986) Hydatidiform mole in England and Wales 1973–1983. Lancet I: 673–677

    Article  Google Scholar 

  • Bagshawe K, Lawler S, Paradinas F, Dent J, Brown P, Boxer G (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335: 1074

    Article  PubMed  CAS  Google Scholar 

  • Bakri Y, Subhi J, Amer M, Ezzat A, Sinner W, Tweijry A, Jabbar F (1993) Liver metastases of gestational trophoblastic tumor. Gynecol Oncol 48: 110–113

    Article  PubMed  CAS  Google Scholar 

  • Barter J, Soong S, Hatch K, Orr J, Partridge E, Austin M, Shingleton H (1987) Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. Am J Obstet Gynecol 157: 1166–1168

    PubMed  CAS  Google Scholar 

  • Barter J, Soong S, Hatch K, Orr J, Partridge E, Austin M, Shingleton H (1989) Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate. Gynecol Oncol 33: 82–84

    Article  PubMed  CAS  Google Scholar 

  • Begent R (1993) Gestational trophoblastic tumors. In: Burghardt E, Webb M, Monaghan J, Kindermann G (eds) Surgical Gynecologic Oncology. Thieme, Stuttgart, S 525–537

    Google Scholar 

  • Berek J (1986) Gestational trophoblastic neoplasia. In: Hacker N, Moore G (eds) Essentials of Obstetrics and Gyneology. Saunders, Philadelphia, pp 509–516

    Google Scholar 

  • Berkowitz R, Goldstein D, Marean A, Bernstein M (1981) Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol 58: 474

    PubMed  CAS  Google Scholar 

  • Berkowitz R, Goldstein D, Bernstein M (1986) Ten years experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 23: 111

    Article  PubMed  CAS  Google Scholar 

  • Berkowitz R, Goldstein D, Bernstein M, Sablinska B (1987) Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors. J Reprod Med 32: 680–684

    PubMed  CAS  Google Scholar 

  • Berkowitz R, Goldstein D, Bernstein M (1990) Methotrexate infusion and folinc acid in the primary therapy of non-metatstatic gestational trophoblastic tumors. Gynecol Oncol 36: 56–59

    Article  PubMed  CAS  Google Scholar 

  • Berkowitz R, Bernstein M, Laborde O, Goldstein D (1994) Subsequent pregnancy experience in patients with gestational trophoblastic disease: New England Trophoblastic Disease Center. J Reprod Med 39: 228–232

    PubMed  CAS  Google Scholar 

  • Chen R, Huang S, Chow S, Hsieh C, Hsu H (1994) Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedant pregnancy. Br J Obstet Gynecol l01: 330–334

    Google Scholar 

  • Cheung A, Sit A, Chung L, Ngan H, O’Hanlan K, Wong L, Ma H (1994) Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridization. Gynecol Oncol 55: 386–392

    Article  PubMed  CAS  Google Scholar 

  • Crawford R, Newlands E, Rustin G, Holden L, A’Hern R, Bagshawe K (1997) Gestational trophoblastic disease with liver metastases: the Charing Cross experience. Brit J Obstet Gynaecol 104: 105–109

    Article  CAS  Google Scholar 

  • Curry S, Blessing J, DiSaia P, Soper J, Twiggs L (1989a) A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in “poor prognosis” metastatic gestational trophoblastic disease: a Gynecologic Oncology Group Study. Obstet Gynecol 73: 357–362

    CAS  Google Scholar 

  • Curry S, Schlaerth J, Kohorn E, Boyce J, Gore H, Twiggs L, Blessing J (1989b) Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). Am J Obstet Gynecol 160: 805–811

    CAS  Google Scholar 

  • DuBeshter B, Berkowitz R, Goldstein D, Cramer D, Bernstein M (1987) Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center,1965 to 1985. Obstet Gynecol 69: 390–395

    PubMed  CAS  Google Scholar 

  • DuBeshter B, Berkowitz R, Goldstein D, Bernstein M (1988) Analysis of treatment failure in high-risk metastatic gestational trophoblastic disease. Gynecol Oncol 29: 199–207

    Article  PubMed  CAS  Google Scholar 

  • Dubuc-Lissoir J, Sweizig S, Schlaerth J, Morrow P (1992) Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems. Gynecol Oncol 45: 40–45

    Article  PubMed  CAS  Google Scholar 

  • Einhorn N (1992) Evolution and current status of gynecologic cancer staging. Curr Prob Obstet Gynecol Fertil 15: 251–268

    Google Scholar 

  • Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J (1994) High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol 54: 282–287

    Article  PubMed  CAS  Google Scholar 

  • Evans A, Soper J, Clarke-Pearson D, Berchuck A, Rodriguez G, Hammond C (1995) Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 59: 226–230

    Article  PubMed  Google Scholar 

  • Fasoli M, Ratti E, Farnceschi S, Ratti E, Franceschi S, Vecchia C, Pecorelli S, Mangioni C (1982) Management of gestational trophoblastic disease: results of a cooperative study. Obstet Gynecol 60: 205–209

    PubMed  CAS  Google Scholar 

  • Genest D, Laborde O, Berkowitz R, Goldstein D, Bernstein M, Lage J (1991) A clinicopathologic study of 153 cases of complete hydatidiform mole (1980–1990): histologic grade lacks prognostic significance. Obstet Gynecol 78: 402–409

    PubMed  CAS  Google Scholar 

  • Goldstein D, Berkowitz R (1984a) Staging system for gestational trophoblastic tumors. J Reprod Med 29: 792

    CAS  Google Scholar 

  • Goldstein D, Berkowitz R, Bernstein M (1984b) Reproductive performance after molar pregnancy and gestational trophoblastic tumors. Clin Obstet Gynecol 27: 221

    Article  CAS  Google Scholar 

  • Gordon A, Kavanagh J, Gershenson D, Saul P, Copeland L, Stringer A (1986) Cisplatin, vinblastine, and bleomycin combination chemotherapy in resistant gestational trophoblastic disease. Cancer 58: 1407–1410

    Article  PubMed  CAS  Google Scholar 

  • Goto S, Yamada A, Ishizuka T, Tomoda Y (1993) Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48: 165–170

    Article  PubMed  CAS  Google Scholar 

  • Hammond C, Borchert L, Tyrey L, Creasman W, Parker R (1973) Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol 115: 451–454

    PubMed  CAS  Google Scholar 

  • Hammond C, Soper J (1984) Poor-prognosis metastatic gestational trophoblastic neoplasia. Clin Obstet Gynecol 27: 228

    Article  PubMed  CAS  Google Scholar 

  • Hammond C, Lewis J, Mutch D (1988) Gestational trophoblastic neoplasms. In: Buchsbaum H, Sciarra J (eds) Gynecology and Obstetrics, Vol. 4. Lippincott, Philadelphia 48: 1–29

    Google Scholar 

  • Heintz A, Schaberg A, Engelsman E, van Hall E (1985) Placental-site trophoblastic tumor: diagnosis, treatment and biological behavior. Int J Gynecol Pathol 4: 75

    Article  PubMed  CAS  Google Scholar 

  • Homesley H, Blessing J, Rettenmaier M, Capizzi R, Major F, Twiggs L (1988) Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 72: 413–418

    PubMed  CAS  Google Scholar 

  • How J, Scurry J, Grant P, Sapountzis K, Ostor A, Fortune D, Armes J (1995) Placental site trophoblastic tumor. Report of three cases and review of the literature. Int J Gynecol Cancer 5: 241–249

    Article  PubMed  Google Scholar 

  • Hunter V, Raymond E, Christensen C, Olt G, Soper J, Hammond C (1990) Efficacy of the metastatic survey in the staging of gestational trophoblastic disease. Cancer 65: 1647–1650

    Article  PubMed  CAS  Google Scholar 

  • Jones W (1987) Current management of low-risk metastatic gestational trophoblastic disease. J Reprod Med 32: 653–656

    PubMed  CAS  Google Scholar 

  • Jones W, Romain K, Erlandson R, Burt M, Lewis J (1993) Thoracotomy in the management of gestational choriocarcinoma. Cancer 72: 2175–2181

    Article  PubMed  CAS  Google Scholar 

  • Jones W, Schneider J, Shapiro F, Lewis J (1996) Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol 61: 126–130

    Article  PubMed  CAS  Google Scholar 

  • Kajii T, Ohama K (1977) Androgenetic origin of hydatidiform mole. Nature 268: 633

    Article  PubMed  CAS  Google Scholar 

  • Kashimura Y, Kashimura M, Sugimori H et al. (1986) Prophylactic chemotherapy for hydatidiform mole. Cancer 58: 624–629

    Article  PubMed  CAS  Google Scholar 

  • Köchli OR (1994) Staging der malignen Trophoblasterkrankungen: Ein Dilemma. Gynäkol Geburtsh Rundsch 34: 3–6

    Article  Google Scholar 

  • Köchli OR, Schär G, Sevin BU et al. (1995) In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms. Anti Cancer Drugs 6: 94–100

    Article  Google Scholar 

  • Kohorn E (1987) Nonmetastatic gestational trophoblastic neoplasia. J Reprod Med 32: 644–651

    PubMed  CAS  Google Scholar 

  • Kohorn E, Klating T, Blood M, Chambers J, Schwartz P (1985) Gestational trophoblastic neoplasia in Southern Connecticut: the experience at the Yale Trophoblastic Center 1971–1983. Connecticut Medicine 49: 141–145

    PubMed  CAS  Google Scholar 

  • Kohorn E (1993) Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 48: 139–147

    Article  PubMed  CAS  Google Scholar 

  • Kohorn E (1995) The trophoblastic tower of Sable: classification systems for metastatic gestational trophoblastic neoplasia. Gynecol Oncol 56: 280–288

    Article  PubMed  CAS  Google Scholar 

  • Lage J, Berkowitz R, Rice L, Goldstein D, Bernstein M, Weinberg D (1991) Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol 77: 111–115

    PubMed  CAS  Google Scholar 

  • Lewis J (1993) Diagnosis and management of gestational trophoblastic disease. Cancer 71: 1639–1647

    Article  PubMed  Google Scholar 

  • Li-Pai C, Shu-Mo C, Jian-Xuan F, Zi-Ting L (1995) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma. Gynecol Oncol 56: 231–234

    Article  Google Scholar 

  • Liu T, Deppe G, Chang Q, Tan T (1983) Cerebral metastatic choriocarcinoma in the People’s Republic of China. Gynecol Onco1 15: 166

    Article  CAS  Google Scholar 

  • Lotz J, Machover D, Malassagne B et al. (1990) Phase I-II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors. J Clin Oncol 9: 1860–1870

    Google Scholar 

  • Lotz J, Andre T, Donsimoni R et al. (1995) High-dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer 75: 874–885

    Article  PubMed  CAS  Google Scholar 

  • Lurain J, Brewer J, Torok E, Halpern B (1982) Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 60: 354

    PubMed  CAS  Google Scholar 

  • Lurain J, Brewer J, Torok E, Halpern B (1983) Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145: 591

    PubMed  CAS  Google Scholar 

  • Lurain J, Brewer J (1985) Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy. Obstet Gynecol 65: 830

    PubMed  CAS  Google Scholar 

  • Lurain J, Casanova L, Miller D, Rademaker A (1991) Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol 164: 611–616

    PubMed  CAS  Google Scholar 

  • Lurain J, Elfstrand E (1995) Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 172: 574–579

    Article  PubMed  CAS  Google Scholar 

  • Martin D, Sutton G, Ulbright T, Sledge G, Stehman F, Ehrlich C (1989) DNA content as a prognostic index in gestational trophoblastic neoplasia. Gynecol Oncol 34: 383–388

    Article  PubMed  CAS  Google Scholar 

  • Mazur M, Kurman R (1982) Gestational trophoblastic disease. In: Kurman R (ed) Blaustein’s Pathology of the Female Genital Tract. Springer, New York Berlin Heidelberg London Paris Tokyo, pp 835–875

    Google Scholar 

  • Mutch D, Soper J, Babcock C, Clarke-Pearson D, Hammond C (1990) Recurrent gestational trophoblastic disease. Cancer 66: 978–982

    Article  PubMed  CAS  Google Scholar 

  • Newlands E, Bagshawe K, Begent R, Rustin G, Holden L, Dent J (1986) Developments in chemotherapy for medium-and high-risk patients with gestational trophoblastic tumours (1979–1984). Br J Obstet Gynaecol 93: 63

    Article  PubMed  CAS  Google Scholar 

  • Newlands E, Bagshawe K, Begent R, Rustin,G, Holden L (1991) Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumors, 1979–1989. Br J Obstet Gynaecol 98: 550–557

    Article  PubMed  CAS  Google Scholar 

  • Ngan H, Lopes A, Lauder I, Martin B, Wong L, Ma H (1994) An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int J Gynecol Cancer 4: 36–42

    Article  PubMed  Google Scholar 

  • Parazzini F, Mangili G, La Vecchia C, Negri E, Bocciolone L, Fasoli M (1991) Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles. Obstet Gynecol 78: 1039–1045

    PubMed  CAS  Google Scholar 

  • Park W (ed) (1971) Choriocarcinoma: a study of its pathology. Davis, Philadelphia

    Google Scholar 

  • Petrilli E, Twiggs L, Blessing J, Teng N, Curry S (1987) Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. Cancer 60: 2173–2176

    Article  PubMed  CAS  Google Scholar 

  • Rustin G, Newlands E, Begent R, Dent R, Bagshawe K (1989) Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 7: 900–903

    PubMed  CAS  Google Scholar 

  • Schink J, Singh D, Rademaker A, Miller D, Lurain J (1992) Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol 80: 817–820

    PubMed  CAS  Google Scholar 

  • Sheline G, Wara W, Smith V (1980) Therapeutic irradiation and brain injury. Int J Radiol Oncol Biol Phys 6: 1215

    Article  CAS  Google Scholar 

  • Smith D, Holden L, Newlands E, Bagshawe K (1993) Correlation between clinical staging (FIGO) and prognostic subgroups with gestational trophoblastic disease. Br J Obstet Gynaecol 100: 157–160

    Article  PubMed  CAS  Google Scholar 

  • Song H, Wu P, Wang Y, Yang X, Dong S (1988) Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. Am J Obstet Gyne-col 158: 538–545

    CAS  Google Scholar 

  • Soper J, Hammond C (1987) Role of surgical therapy and radiotherapy in gestational trophoblastic disease. J Reprod Med 32: 663–668

    PubMed  CAS  Google Scholar 

  • Soper J, Clarke-Pearson D, Hammond C (1988) Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol 71: 338–343

    PubMed  CAS  Google Scholar 

  • Soper J, Evans A, Conaway M, Clarke-Pearson D, Berchuck A, Hammond C (1994a) Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol 84: 969–973

    CAS  Google Scholar 

  • Soper J, Clarke-Pearson D, Berchuck A, Rodriguez G, Hammond C (1994b) 5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 54: 76–79

    Article  CAS  Google Scholar 

  • Soper J, Evans C, Clarke-Pearson D, Berchuck A, Rodriguez G, Hammond C (1994c) Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 83: 113–117

    CAS  Google Scholar 

  • Soper J, Evans A, Rodriguez G, Berchuck A, Clarke-Pearson D, Hammond C (1995) Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. Gynecol Oncol 56: 421–424

    Article  PubMed  CAS  Google Scholar 

  • Surwit E, Alberts D, Christian C, Graham V (1984) Poor-prognosis gestational trophoblastic disease. An update. Obstet Gynecol 64: 21

    Article  PubMed  CAS  Google Scholar 

  • Sutton G, Soper J, Blessing J, Hatch K, Barnhill D (1992) Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Ob-stet Gynecol 167: 489–495

    CAS  Google Scholar 

  • Theodore C, Azab M, Droz J, et al. (1989) Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. Cancer 64: 1824–1828

    Article  PubMed  CAS  Google Scholar 

  • Van Thiel D, Ross G, Lipsett M (1970) Pregnancies after chemotherapy of trophoblastic neoplasms. Science 169: 1326

    Article  PubMed  Google Scholar 

  • World Health Organization Scientific Group on Gestational Trophoblastic Disease (1983) Gestational trophoblastic diseases. Technical Report Series 692. WHO, Geneva

    Google Scholar 

  • Wong L, Choo Y, Ma H (1985) Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 152: 59

    PubMed  CAS  Google Scholar 

  • Wong L, Choo Y, Ma H (1986) Primary oral etoposide therapy in gestational trophoblastic disease: an update. Cancer 58: 14

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Petru
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. R. Kochli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B.-U. Sevin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Petru, E., Kochli, O.R., Sevin, BU. (1998). Trophoblasttumoren. In: Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58756-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58756-6_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63713-1

  • Online ISBN: 978-3-642-58756-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation